The multivariate survival analysis using Cox’s regression model, which included hormonal status, ER status and YAP1 expression category (low or high), identified YAP1 overexpression as an independent indicator of bad prognosis in the cohort of HER2+ metastatic breast cancer patients (p < 0.01) (Table S5). The gene discussed is ERBB2; the disease is breast cancer.